文献速递乳房整形与再造创面修复

乳房再造乳头乳晕复合体纹饰11年机构回顾:纹饰相关感染并发症危险因素

An 11-year Institutional Review of Nipple-Areolar Complex Tattooing for Breast Reconstruction: Identifying Risk Factors for Development of Tattoo-related Infectious Complications.
PubMed 文献 · Ann Plast Surg · 2021-01-01

该研究回顾11年539例(949只乳房)乳头乳晕复合体纹饰患者,纹饰相关感染率为2.2%。多因素分析显示放疗史(OR 4.1,P=0.007)和胸肌前假体再造(OR 2.8,P=0.036)是独立预测因素。建议对高危患者考虑术前预防性抗生素。

要点

  • 纹饰相关感染率2.2%,平均感染时间6.5±5.3天。
  • 放疗史与胸肌前假体再造是独立感染预测因素。
  • 放疗后假体再造者感染风险高于自体重建。

核心结论

  • 纹饰相关感染不常见,但放疗史和胸肌前假体再造是独立预测因素。
  • 高危患者可考虑术前预防性抗生素以降低感染风险。

研究设计与样本

  • 回顾性机构审查,纳入2009年1月至2020年3月行乳头乳晕复合体纹饰的患者。
  • 共539例患者、949只乳房,分析患者信息、重建及纹饰操作细节。
  • 纹饰相关感染定义为纹饰后30天内需抗生素治疗的乳房发红,排除术后2天内反应性发红。

主要发现

  • 949只乳房中,假体再造占73.6%(n=698),自体重建占26.4%(n=251)。
  • 脱细胞真皮基质用于57.6%(n=547)的乳房,纹饰前放疗占13.7%(n=130)。
  • 胸肌下假体再造占65.3%(n=456),胸肌前假体再造占34.7%(n=242)。
  • 纹饰相关感染率为2.2%(n=21只乳房),平均感染时间6.5±5.3天。
  • 感染中85.7%(n=18)发生于假体再造患者,其中三分之一发生于放疗患者。

临床怎么用

  • 对有放疗史或胸肌前假体再造的患者,纹饰前可考虑预防性抗生素。
  • 纹饰后30天内出现乳房发红需警惕感染,尤其在高危患者中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nipple-areolar complex (NAC) tattooing remains a simple and safe procedure, which complements breast reconstruction. This study reviews 11 years of NAC tattooing to identify risk factors for tattoo-related complications. METHODS: Patients undergoing NAC tattooing from January 2009 to March 2020 were reviewed. Patient information, reconstructive, and tattoo procedural details were analyzed. Tattoo-related breast infections, defined as breast redness requiring antibiotic therapy within 30 days after tattoo, were captured. Patients with reactive breast redness during the first 2 postprocedural days were excluded. RESULTS: Overall, 539 patients (949 breasts) were included. Implant-based reconstruction (IBR) was performed in 73.6% of breasts (n = 698), whereas 26.4% (n = 251) underwent autologous-based reconstruction (ABR). Acellular-dermal matrix was used in 547 breasts (57.6%). There as a 13.7% (n = 130) of breasts that underwent pretattoo radiation. There was a 65.3% (n = 456) of breasts that underwent subpectoral IBR, whereas 34.7% (n = 242) breasts underwent prepectoral IBR. Tattoo-related infection rate was 2.2% (n = 21 breasts). Mean time to infection was 6.5 ± 5.3 days. There was a 85.7% (n = 18) of infections that occurred in IBR patients, one third occurring in radiated patients. There was a 95.2% (n = 20) of infections that were treated with oral antibiotics only. One explantation was performed after failed intravenous antibiotics. On multivariable analysis, radiation history (odds ratio, 4.1, P = 0.007) and prepectoral IBR (odds ratio, 2.8, P = 0.036) were independent predictors of tattoo-related infection. Among irradiated breasts, breasts with IBR had greater odds of developing tattoo-related infection versus breasts with ABR (P = 0.025). CONCLUSIONS: Although tattoo-related infections were uncommon, previous radiation and prepectoral IBR were both found to be independent predictors of tattoo-related breast infection. There is a role for preprocedural prophylactic antibiotics in these patients to mitigate infectious risk.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Weissler JM, Kuruoglu D, Curiel D, et al. An 11-year Institutional Review of Nipple-Areolar Complex Tattooing for Breast Reconstruction: Identifying Risk Factors for Development of Tattoo-related Infectious Complications. Ann Plast Surg. 2021. PMID: 33833170. doi:10.1097/SAP.0000000000002820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。